A number of case studies reported a strong expression of PTHrP in pancreatic adenocarcinoma (90), intrahepatic cholangiocarcinoma (91), pancreatic neuroendocrine cancer and that PTHrP levels were elevated in the patient serum (92). This evidence concerns the gene PTHLH and pancreatic adenocarcinoma.